Pfizer has announced that they will establish the U.S. cost for its COVID-19 antiviral therapy Paxlovid at roughly 1,400 ...
The PM Society and Word Monster are collaborating to raise quality and develop expertise in the medical communications sector ...
In the UK and throughout Europe, Antech, a division of Mars Science and Diagnostics, has introduced a novel cancer test for ...
Researchers at the University of Edinburgh’s School of Chemistry presented an innovative, environmentally friendly process ...
GSK has reported positive outcomes from a late-stage study on gepotidacin, an oral treatment for urogenital gonorrhoea in adults. The study aimed to evaluate the safety profile of gepotidacin when ...
Henry Schein welcomes three new members to the executive management committee. The new members include Steve Boggan, Bianka Wilson, and Tom Popeck. Henry Schein’s Global Oral Reconstruction Group is a ...
Oncocyte and Bio-Rad Laboratories have collaborated on the marketing of GraftAssure assay. While Oncocyte will spearhead the marketing, the two companies will collaborate for the commercialization of ...
Abbvie’s migraine treatment has received a final draft guidance from the National Institute for Health and Care Excellence for NHS use in over 18-year-olds. The treatment ‘Aquipta’ can be used for the ...
LCW Medical Communications Client Service Officer, Kelly Farley, and CEO, Lucy Williams, have unveiled the procurement of Mediconf UK. LCW Medical Communications is a company that specialises in ...
Paroxysmal nocturnal hemoglobinuria is a rare, acquired disorder characterised by the abnormal breakdown of red blood cells, leading to symptoms such as hemolytic anaemia, thrombosis, and bone marrow ...
[Alphen aan den Rijn, Netherlands – 16th April 2024] – Life Science Newswire – It is with great pleasure that Sakura Finetek Europe announces the appointment of Jaap Stuut as the President and General ...
Sanofi’s natural killer cell engager enters a second stage study to assess the candidate’s ability to treat various types of blood cancers. The study aims to examine the candidate’s safety, its ...